+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anticoagulant Reversal Agent Market - Global Forecast 2025-2030- Product Image
Anticoagulant Reversal Agent Market - Global Forecast 2025-2030- Product Image
Sale

Anticoagulant Reversal Agent Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6127998
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Anticoagulant reversal agents are reshaping the clinical and operational landscape of thrombotic event management, as rising adoption of direct oral anticoagulants highlights the need for targeted, safe, and rapid reversal solutions. Balancing efficacy with patient safety has become mission-critical amid evolving risk profiles and regulatory demands in acute care settings.

Market Snapshot: Anticoagulant Reversal Agent Market Growth and Dynamics

The anticoagulant reversal agent market is experiencing robust momentum, catalyzed by a shift from broad-spectrum plasma products to novel agents engineered for rapid and specific intervention. This evolution is amplified by best-practice protocols in emergency surgery, intracranial hemorrhage, and major bleeding incidents. Hospitals, trauma centers, and ambulatory facilities increasingly favor precision-based treatment pathways. Life science innovators and payers are recalibrating resource allocation and reimbursement frameworks to keep pace, driving further adoption and competition within the sector.

Scope & Segmentation

This comprehensive report delivers a detailed review across the entire value chain for the anticoagulant reversal agent market, structured into actionable segments and regional clusters.

  • Product Types: Andexanet Alfa, Fresh Frozen Plasma, Idarucizumab, Prothrombin Complex Concentrate (including Four-Factor PCC and Three-Factor PCC), Vitamin K
  • Indications: Emergency Surgery, Gastrointestinal Bleeding, Intracranial Hemorrhage, Major Bleeding Events
  • End Users: Ambulatory Surgical Centers, Clinics, Hospitals, Trauma Centers
  • Distribution Channels: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
  • Routes of Administration: Intravenous, Oral
  • Geographical Coverage:
    • Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina)
    • Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland)
    • Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Company Coverage: Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Pfizer Inc., Fresenius Kabi AG, B. Braun Melsungen AG, Baxter International Inc., Viatris Inc., Sandoz International GmbH, Sagent Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC

Key Takeaways

  • Targeted biologics such as Andexanet Alfa and Idarucizumab are preferred for rapid, mechanism-specific reversal in acute scenarios, offering clinical advantages over plasma-derived and broad-spectrum alternatives.
  • Emergent digital health tools—such as point-of-care diagnostics and predictive analytics—are being deployed to streamline clinical decision-making and optimize therapeutic outcomes.
  • Regional disparities, particularly in Europe, Middle East & Africa, shape product accessibility and necessitate regionally tailored strategies for procurement, reimbursement, and clinician education.
  • Strategic alliances between manufacturers, plasma collection centers, and diagnostic vendors foster innovation, supply chain resilience, and market penetration.
  • Education initiatives for care teams and integration into protocol-based workflows are accelerating best-practice adoption and supporting improved patient outcomes across both inpatient and outpatient contexts.

Tariff Impact: Navigating the Effects of 2025 U.S. Tariff Modifications

The introduction of revised United States tariffs in 2025 is impacting the anticoagulant reversal agent supply chain, particularly for plasma derivatives and recombinant proteins. Increased import duties have prompted investments in domestic production and restructured logistics strategies, influencing cost structures and access across both public and private care segments.

Methodology & Data Sources

This analysis synthesizes rigorous primary and secondary research. In-depth interviews with clinical leaders and procurement stakeholders across North America, EMEA, and Asia-Pacific are complemented by a review of journals, trial registries, regulatory dossiers, and proprietary datasets. Data triangulation and independent peer review ensure accuracy and relevance for strategic use.

Why This Report Matters

  • Enables senior decision-makers to benchmark product performance, regional trends, and emerging risks across segmented domains.
  • Supports informed investment, supply chain, and clinical adoption decisions with actionable insights specific to evolving regulatory and technological considerations.
  • Delivers an integrated market perspective suited for strategic planning and operational execution in rapidly evolving healthcare environments.

Conclusion

With its focus on product innovation, regulatory shifts, and competitive agility, this report provides actionable guidance to help organizations enhance patient care and operational efficiency in the anticoagulant reversal agent market.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of andexanet alfa for urgent reversal of factor Xa inhibitors in emergency settings
5.2. Increasing pipeline focus on monoclonal antibody antidotes for direct thrombin inhibitor reversal
5.3. Expansion of hospital formularies to include four-factor prothrombin complex concentrates for rapid warfarin reversal
5.4. Emerging real-world evidence demonstrating cost-effectiveness of idarucizumab in dabigatran overdose management
5.5. Regulatory approvals and label expansions of emergent reversal agents across US and EU markets
5.6. Collaborations between pharmaceutical firms and academic centers to develop next-generation reversal therapies
5.7. Rising patient and clinician preference for point-of-care coagulation testing to guide reversal agent administration
5.8. Development of subcutaneous and intranasal delivery platforms to improve anticoagulant reversal agent accessibility
5.9. Growing emphasis on pharmacovigilance data integration to enhance safety of novel reversal agents
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Anticoagulant Reversal Agent Market, by Product Type
8.1. Introduction
8.2. Andexanet Alfa
8.3. Fresh Frozen Plasma
8.4. Idarucizumab
8.5. Prothrombin Complex Concentrate
8.5.1. Four-Factor Pcc
8.5.2. Three-Factor Pcc
8.6. Vitamin K
9. Anticoagulant Reversal Agent Market, by Indication
9.1. Introduction
9.2. Emergency Surgery
9.3. Gastrointestinal Bleeding
9.4. Intracranial Hemorrhage
9.5. Major Bleeding Events
10. Anticoagulant Reversal Agent Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Hospitals
10.5. Trauma Centers
11. Anticoagulant Reversal Agent Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Anticoagulant Reversal Agent Market, by Route of Administration
12.1. Introduction
12.2. Intravenous
12.3. Oral
13. Americas Anticoagulant Reversal Agent Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Anticoagulant Reversal Agent Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Anticoagulant Reversal Agent Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Takeda Pharmaceutical Company Limited
16.3.2. Boehringer Ingelheim International GmbH
16.3.3. Pfizer Inc.
16.3.4. Fresenius Kabi AG
16.3.5. B. Braun Melsungen AG
16.3.6. Baxter International Inc.
16.3.7. Viatris Inc.
16.3.8. Sandoz International GmbH
16.3.9. Sagent Pharmaceuticals, Inc.
16.3.10. Amneal Pharmaceuticals LLC
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ANTICOAGULANT REVERSAL AGENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANTICOAGULANT REVERSAL AGENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANTICOAGULANT REVERSAL AGENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ANTICOAGULANT REVERSAL AGENT MARKET: RESEARCHAI
FIGURE 26. ANTICOAGULANT REVERSAL AGENT MARKET: RESEARCHSTATISTICS
FIGURE 27. ANTICOAGULANT REVERSAL AGENT MARKET: RESEARCHCONTACTS
FIGURE 28. ANTICOAGULANT REVERSAL AGENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTICOAGULANT REVERSAL AGENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ANDEXANET ALFA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ANDEXANET ALFA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY IDARUCIZUMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY IDARUCIZUMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY FOUR-FACTOR PCC, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY FOUR-FACTOR PCC, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY THREE-FACTOR PCC, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY THREE-FACTOR PCC, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY VITAMIN K, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY VITAMIN K, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY EMERGENCY SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY EMERGENCY SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY GASTROINTESTINAL BLEEDING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY GASTROINTESTINAL BLEEDING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INTRACRANIAL HEMORRHAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INTRACRANIAL HEMORRHAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY MAJOR BLEEDING EVENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY MAJOR BLEEDING EVENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY TRAUMA CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY TRAUMA CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 89. CANADA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. CANADA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. CANADA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 92. CANADA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 93. CANADA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 94. CANADA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 95. CANADA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. CANADA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. CANADA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. CANADA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. CANADA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 100. CANADA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 101. MEXICO ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. MEXICO ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. MEXICO ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 105. MEXICO ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. MEXICO ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. MEXICO ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. MEXICO ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. MEXICO ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. MEXICO ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. MEXICO ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 112. MEXICO ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. GERMANY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. GERMANY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. GERMANY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 166. GERMANY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 167. GERMANY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. GERMANY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. GERMANY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. GERMANY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. GERMANY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. GERMANY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. GERMANY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. GERMANY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. FRANCE ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. FRANCE ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. FRANCE ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 178. FRANCE ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 179. FRANCE ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. FRANCE ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. FRANCE ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. FRANCE ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. FRANCE ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. FRANCE ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. FRANCE ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. FRANCE ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 199. ITALY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. ITALY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. ITALY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 202. ITALY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 203. ITALY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. ITALY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. ITALY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. ITALY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. ITALY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. ITALY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. ITALY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. ITALY ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. SPAIN ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. SPAIN ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. SPAIN ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 214. SPAIN ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 215. SPAIN ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. SPAIN ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. SPAIN ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. SPAIN ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. SPAIN ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. SPAIN ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. SPAIN ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. SPAIN ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 246. SAUDI ARABIA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 258. SOUTH AFRICA ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 259. DENMARK ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. DENMARK ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. DENMARK ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 262. DENMARK ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 263. DENMARK ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. DENMARK ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. DENMARK ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. DENMARK ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. DENMARK ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. DENMARK ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. DENMARK ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. DENMARK ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. NETHERLANDS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 282. NETHERLANDS ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 283. QATAR ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. QATAR ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. QATAR ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 286. QATAR ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 287. QATAR ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. QATAR ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. QATAR ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. QATAR ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. QATAR ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. QATAR ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. QATAR ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 294. QATAR ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 295. FINLAND ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. FINLAND ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. FINLAND ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2018-2024 (USD MILLION)
TABLE 298. FINLAND ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, 2025-2030 (USD MILLION)
TABLE 299. FINLAND ANTICOAGULANT REVERSAL AGENT MARKET SIZE, BY INDICATION, 2

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Anticoagulant Reversal Agent market report include:
  • Takeda Pharmaceutical Company Limited
  • Boehringer Ingelheim International GmbH
  • Pfizer Inc.
  • Fresenius Kabi AG
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Viatris Inc.
  • Sandoz International GmbH
  • Sagent Pharmaceuticals, Inc.
  • Amneal Pharmaceuticals LLC

Related Topics

Related Reports

Anticoagulant Reversal Drugs Market - Global Forecast 2025-2030 - Product Image

Anticoagulant Reversal Drugs Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Anticoagulant Reversal Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Anticoagulant Reversal Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 91 Pages
  • Global
From
Anticoagulant Reversal Drugs Market Size, Share & Trends Analysis Report By Product Type (Andexanet Alfa, Idarucizumab, Phytonadione (Vitamin K)), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Anticoagulant Reversal Drugs Market Size, Share & Trends Analysis Report By Product Type (Andexanet Alfa, Idarucizumab, Phytonadione (Vitamin K)), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Anticoagulant Reversal Drugs - Global Strategic Business Report - Product Image

Anticoagulant Reversal Drugs - Global Strategic Business Report

  • Report
  • 140 Pages
  • Global
From
Direct Oral Anticoagulants Market - Global Forecast 2025-2030 - Product Image

Direct Oral Anticoagulants Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.